Chungsim-Yeunja-Tang decreases the inflammatory response in peripheral blood mononuclear cells from patients with cerebral infarction through an NF-κB dependent mechanism

BACKGROUND: Chungsim-Yeunja-Tang (CYT) has been used as a medicine for cerebral infarction (CI) patients in Korea. The objective of this study was to determine precisely the effect of CYT on CI patients using peripheral blood mononuclear cells (PBMCs). METHODS: For a clinical study, 47 CI patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Hyun-Ja, Choi, In-Young, Kim, Min-Ho, Kim, Hyung-Min, Moon, Phil-Dong, Hong, Jin-Woo, Kim, Soo-Hyun
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3009630/
https://www.ncbi.nlm.nih.gov/pubmed/21108840
http://dx.doi.org/10.1186/1742-2094-7-85

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3009630/
https://www.ncbi.nlm.nih.gov/pubmed/21108840
http://dx.doi.org/10.1186/1742-2094-7-85

Ejemplares similares